2018 Camp Fire FireFighter Biomonitoring Study (Update 8/22/20)
SFFCPF commissioned the Camp Fire Study following the Paradise, CA Wildland Fire in partnership with Commonweal. 80 Firefighters responding from regional departments were sampled immediately post-deployment. The biospecimens were tested for chemical toxicants, including heavy metals, flame retardants, stain and water repellent substances, PAH’s and PFAS likely encountered on the fire ground. Chemical Body Burden Levels were released to each firefighter participant as they became available. On August 22, 2020, the aggregate study results were released indicating that immediately post-fire, firefighters were carrying in their bodies, a mixture of these chemical toxicants at levels higher than those found in the general US population.The majority of these chemicals are considered to be carcinogens, many of them associated with cardiovascular, reproductive, kidney and liver dysfunction. Of special concern is the exposure to PFAS, some of which are immune-suppressors that damage the body’s capacity to protect against disease. This study was funded by SFFCPF with contributions from the International Association of Firefighters (IAFF). Download the full Study Overview HERE.
2020 Stanford Retired Firefighter Wildfire and Health Study
SFFCPF partners with Stanford University’s Study of Retired San Francisco Firefighters investigating short-term and long-term health impacts of exposure to California wildfire smoke. If you are interested in participating or learning more, check out Stanford’s Wildfire and Health Study.
2020 Stanford Active Firefighter Home Kit Acute Exposure Study
In August 2020, SFFCPF agrees to collaborate in a study of active SFFD firefighters exposed to smoke while fighting urban setting fires and/or wildfires while deployed on strike teams. Through simple in-home micro-sampling, the study will create a list of potential biomarkers both pre- and post- smoke exposure that can be used for general firefighters’ risks. The goal is to improve screenings for cancer, along with cardiovascular and respiratory diseases. This study is under design and more information will follow shortly.